Compare up to three stocks to (0MKM.L) by adding the symbol or company name. Compare up to three stocks to (0MKM.L) by adding the symbol or company name.
In a report released today, Jonathan Aschoff from Roth MKM maintained a Buy rating on Aptevo Therapeutics (APVO – Research Report), with a price target of $21.00. The company’s shares closed ...
It halted a run of defeats at the MKM Stadium, but it was another game where they led, only to fail to build on it and be pegged back. Their 33 goals from 34 games are an example of why they're ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback